🚀

North Dakota AI Laws for Startups (1-10) in Healthcare

Focus on documentation and AI disclosure. You may qualify for simplified compliance under the EU Omnibus framework.

By AI Law Tracker Editorial Team · Legal research team

Published Apr 22, 2026Reviewed Apr 22, 2026

AI Compliance Context for North Dakota

As of 2026-04-22, North Dakota has not enacted an AI-specific statute; the North Dakota Attorney General office defers to no comprehensive privacy statute; UDAP coverage via N.D.C.C. sec. 51-15-02. For clinical decision-making and patient-record AI in North Dakota, federal signals set the ceiling while regional precedent sets the floor.

Two neighboring states shape regional expectations: Minnesota's HF 4654 — AI Transparency Act (penalty Civil penalties, deadline August 1, 2026) and Montana's Consumer Data Privacy Act (AI provisions) (penalty Up to $7,500 per violation). Any North Dakota-headquartered operator touching those markets inherits the stricter of the two.

The federal and neighboring-state framework that governs your AI operations. Healthcare operators in North Dakota operate under a federal-dominant framework anchored by HIPAA Privacy Rule (45 CFR 164.502) and FDA SaMD guidance, with adjacent authorities HIPAA Privacy Rule (45 CFR § 164.502(b)); HIPAA Security Rule (45 CFR § 164.308–316); FDA Software as Medical Device (SaMD) Guidance (FDA-2021-D-0074 (updated 2023)). HHS Office for Civil Rights intensified AI-bias investigations in 2025 under HIPAA and Section 1557 of the ACA. The practical risk they have to price in is patient-safety liability and algorithmic bias producing disparate treatment outcomes, and the bellwether signal to monitor is FDA cleared over 950 AI/ML medical devices through 2024 and is issuing real-world performance guidance. Minnesota -- HF 4654 — AI Transparency Act sets the de-facto regional floor. North Dakota 2025 session considered AI task-force resolution; no substantive AI regulation adopted. Use this as a starting point; sector pages on this site go deeper into industry-specific obligations.

North Dakota's non-legislation on AI means the North Dakota Attorney General office has discretion to apply no comprehensive privacy statute to AI-driven consumer harms as they arise.

Federal law still governs Healthcare AI in North Dakota primarily through HIPAA Privacy Rule (45 CFR 164.502) and FDA SaMD guidance. Adjacent federal authorities include HIPAA Privacy Rule (45 CFR § 164.502(b)); HIPAA Security Rule (45 CFR § 164.308–316); FDA Software as Medical Device (SaMD) Guidance (FDA-2021-D-0074 (updated 2023)). HIPAA Privacy Rule (enforced by HHS Office for Civil Rights) applies to ai systems processing patient health information must ensure privacy, consent, and secure transmission. ai-driven diagnosis or treatment recommendations must comply with data minimization. Penalty exposure: $141–$71,162 per violation (2024 adjusted); annual cap $2.13m per tier. HHS Office for Civil Rights intensified AI-bias investigations in 2025 under HIPAA and Section 1557 of the ACA.

With a team of 1-10, your AI-compliance role is usually a founder-owned responsibility rather than a dedicated hire. Startup-stage Healthcare operators should deploy lightweight documentation: single AI-responsible officer, quarterly lightweight review, and outside counsel on retainer, with annual lightweight audit and ownership resting with a founder-delegated AI compliance owner. startup compliance budgets ($10K-$50K annual) can focus on documentation and training rather than dedicated tooling. For Healthcare specifically, the sharpest exposure to manage is patient-safety liability and algorithmic bias producing disparate treatment outcomes. Given North Dakota's concentration in energy, agriculture, and government services, oilfield optimization AI and agricultural supply-chain algorithms deserve priority in your AI inventory.

The enforcement surface for Healthcare centres on HHS OCR, FDA, FTC, and the statute operators most often under-document is HIPAA Security Rule (45 CFR § 164.308–316) — a gap that surfaces in patient-safety liability disputes. Build an evidence binder covering clinician workflow, patient-record access, PHI minimisation, bedside triage, and diagnostic concordance. Treat FDA cleared over 950 AI/ML medical devices through 2024 and is issuing real-world performance guidance as your leading indicator and escalate when the signal shifts.

Verified 2026-04-22. See https://www.legis.nd.gov/ for the North Dakota Attorney General public record on North Dakota AI policy.

Applicable law: No AI-specific law

No state AI law. Energy sector AI use monitored.

HIPAA applies to AI processing patient data. States mandate disclosures when AI assists diagnosis, billing, or scheduling.

Deadline: N/APenalty: N/AStatus: No Law

What this means for Startups (1-10) in Healthcare

For a startups (1-10) healthcare business operating in North Dakota, AI compliance is a concrete and present-tense concern. At this size, most compliance work falls on founders or a small generalist team without dedicated legal or compliance staff. The central challenge is identifying which AI laws apply to your business before a regulator identifies them for you — and understanding exactly what No AI-specific law requires of an organization at your headcount is the essential foundation.

At the startups (1-10) tier, core compliance obligations under North Dakota's framework include disclosure notices on any customer-facing AI, basic documentation of AI systems in use, and a designated point of contact for AI compliance questions. formal impact assessments, dedicated compliance staff, and board-level AI governance programs are not typically required at this headcount — but building good documentation habits now prevents costly retrofits as you scale. This proportionality is deliberate — regulators recognize that smaller organizations cannot sustain the same compliance infrastructure as large enterprises, but the law's fundamental requirements apply regardless of size.

The healthcare sector's very high risk classification takes on particular relevance at this scale. HIPAA applies to AI processing patient data. States mandate disclosures when AI assists diagnosis, billing, or scheduling. For a startups (1-10) business, the risk materializes because identifying which AI laws apply to your business before a regulator identifies them for you is more acute at this size — AI tools from vendors may have been adopted without full compliance review, and operational workflows where AI is embedded often develop faster than governance processes.

The highest-priority actions for a startups (1-10) healthcare business in North Dakota are: (1) inventory every ai tool in use, including free-tier and trial products from third-party vendors; (2) add ai disclosure language to your website privacy policy and customer-facing communications; and (3) designate one person — even a founder — as the ai compliance point of contact and document that designation. These steps do not require outside counsel or enterprise compliance software — they can be executed with existing staff and documented in straightforward internal policies. The goal is to move from informal AI usage to documented AI governance, even if that governance is lightweight at first.

Understanding the financial stakes clarifies the urgency. fines that are modest in absolute terms can be existential for an early-stage company, and a compliance violation can materially complicate fundraising and acquisition due diligence. Under No AI-specific law, the maximum penalty is N/A. For a business at this size, that exposure — especially if it accrues on a per-violation basis across multiple AI touchpoints — warrants taking compliance seriously now rather than reactively. as you cross the 10-employee threshold, your statutory obligations will grow — the foundation you build now determines whether scaling compliance is a straightforward upgrade or a complete rebuild.

Beyond the headline compliance obligations, startups (1-10) healthcare businesses in North Dakota face specific employer and operator duties tied to how AI interacts with people — employees, customers, applicants, and others affected by automated decisions. When AI assists in decisions that affect people's access to services, job opportunities, credit, or housing, North Dakota law treats the deploying organization as responsible for the outcome regardless of whether the underlying model was built in-house or acquired from a vendor. This means startups (1-10) operators cannot outsource accountability to their AI provider — vendor contracts should be reviewed for indemnification provisions, compliance representations, and audit rights. Documenting the due diligence you performed before selecting and deploying an AI system is itself a compliance requirement in several states, and a strong defense in enforcement proceedings.

The compliance timeline for a startups (1-10) healthcare business in North Dakota has several distinct phases. The first phase — inventory and assessment — involves documenting every AI system in use and evaluating whether it falls within the scope of No AI-specific law. Most compliance experts recommend completing this phase within the first 30 days of any new compliance program. The second phase — policy and disclosure — involves drafting the required notices, internal use policies, and vendor agreements. A 60-day target is realistic for most startups (1-10) organizations. The third phase — technical controls and ongoing monitoring — involves implementing audit logs, human review checkpoints for high-stakes decisions, and regular bias testing for any AI that affects protected populations. This phase is ongoing. With North Dakota's deadline of N/A, the first two phases should be completed well before enforcement begins.

The enforcement landscape for AI compliance in North Dakota is evolving, but the direction is consistent: regulators are moving from guidance to action. Once No AI-specific law takes effect in North Dakota, enforcement typically begins immediately against the most visible violations — disclosure failures and bias-related incidents. For startups (1-10) healthcare businesses, the highest-risk scenarios involve automated decisions affecting individuals in ways the law covers: hiring, lending, insurance pricing, and access to services. Regulators typically prioritize cases where AI-driven harm is documented, where disclosure requirements were clearly violated, or where a company failed to provide a mandated appeal or human review process. Building a compliance program now — even a lightweight one appropriate for a startups (1-10) organization — establishes a documented good-faith effort that regulators consistently weigh favorably in enforcement decisions. The cost of getting started is a fraction of the cost of responding to a formal investigation.